GGrantIndex
Sort

27,075 grants matching cholesterol

Genetic analysis of type II diabetes in Finnish population

$2,543,938
Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2015 · HG

Genetic analysis of type II diabetes in Finnish population

$2,543,867
Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2013 · HG

Genetic analysis of type II diabetes in Finnish population

$2,543,663
Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2012 · HG

Genetic analysis of type II diabetes in Finnish population

$2,543,269
Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2014 · HG

Alzheimer's Disease Patient Registry (ADPR/ACT)

$2,540,437
Eric B Larson · Kaiser Foundation Research Institute · U01 · FY2018 · AG

Aging as a Risk Factor and Target for Prevention of Liver Cancer

$2,531,382
Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG

Aging as a Risk Factor and Target for Prevention of Liver Cancer

$2,530,091
Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG

Multidisciplinary Approaches to HDL Structure, Assembly and Function

$2,517,073
Jere P Segrest · Vanderbilt University Medical Center · P01 · FY2016 · HL

HDL Function in Human Disease

$2,512,032
Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2024 · HL

Genetics of Atherosclerosis in Mexican Americans

$2,509,495
John Blangero · Texas Biomedical Research Institute · P01 · FY2008 · HL

Role of O-glycosylation in Animal Development

$2,508,316
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE

Cellular and Molecular Mechanisms of Atherosclerosis

$2,503,865
Alan Richard Tall · Columbia University Health Sciences · P01 · FY2025 · HL

Analytical Chemistry

$2,500,589
Christopher Arthur Leclair · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR

trans-Resveratrol (RES) in Laboratory Animals for the National Toxicology Program

$2,500,000
Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2014 · ES

The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory

$2,499,382
Rima F Kaddurah-Daouk · Duke University · U01 · FY2024 · AG

Apolipoprotein E genotype modulates brain mitovesicle production, a component of mitochondrial quality control

$2,499,343
Efrat Levy · Nathan S. Kline Institute For Psych Res · RF1 · FY2024 · AG

Genetics of Atherosclerosis in Mexican Americans

$2,494,758
John Blangero · Texas Biomedical Research Institute · P01 · FY2006 · HL

Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity

$2,494,366
W. Sean Davidson · University Of Cincinnati · P01 · FY2024 · HL

Genetics of Atherosclerosis in Mexican Americans

$2,491,120
John Blangero · Texas Biomedical Research Institute · P01 · FY2009 · HL

Genetics of Atherosclerosis in Mexican Americans

$2,491,120
John Blangero · Texas Biomedical Research Institute · P01 · FY2011 · HL

Genetics of Atherosclerosis in Mexican Americans

$2,491,120
John Blangero · Texas Biomedical Research Institute · P01 · FY2010 · HL

Genetics of Atherosclerosis in Mexican Americans

$2,491,086
John Blangero · Texas Biomedical Research Institute · P01 · FY2012 · HL

Biogenesis and Catabolism of Atherogenic Lipoproteins

$2,485,299
M Mahmood Hussain · Nyu Long Island School Of Medicine · P01 · FY2023 · HL

New Approaches to Reduce Residual Cardiovascular Risk

$2,484,600
Jay D Horton · Ut Southwestern Medical Center · P01 · FY2022 · HL

New Approaches to Reduce Residual Cardiovascular Risk

$2,484,600
Jay D Horton · Ut Southwestern Medical Center · P01 · FY2023 · HL